Obesity trials in China

In China 251 Also abroad 1939

251 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Beijing, Changchun, Hefei, Herbin, Huizhou, Jinan, Langfang, Luoyang, Nanjing, Pingxiang, Shanghai, Suzhou, Xianyang, Zhenjiang
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Beijing, Cangzhou, Changchun, Hefei, Herbin, Huizhou, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Ningbo, Pingxiang, Shanghai, Siping, Suzhou, Wuxi, Xi'an, Xianyang, Xuzhou, Yueyang, Zhenjiang
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
Where
Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi, Jincheng, Jinzhou Shi, Langfang, Luoyang, Meihekou, Nanjing, Nanyang, Shanghai, Shantou, Shenyang, Shijiazhuang, Wuhan, Wuhu, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
Age
18 years and over
People
351 worldwide
Run by
AstraZeneca
See details and how to joinNCT07775404
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseTaking people
Explore the Weight Loss Effect of Amway "BODY TRIMMER"
Where
Shanghai
Age
30 years to 65 years
People
110
Run by
Amway (China) R&D Center
See details and how to joinNCT07924956
No phaseTaking people
Determination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients
Where
Jinan
Age
18 years to 65 years
People
120
Run by
Jianbo Wu
See details and how to joinNCT07925684
Phase 3Taking people
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity
Where
Beijing, Hefei, Huizhou, Nanchang, Nanjing, Zhengzhou
Age
18 years and over
People
432
Run by
Pfizer
See details and how to joinNCT07874633
Phase 3Not yet taking people in China
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Where
Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
Age
18 years and over
People
330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07922330
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
Where
Hefei
Age
18 years to 65 years
People
126
Run by
Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT07102251
Phase 3Taking people
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Where
Beijing, Changchun, Hefei, Herbin, Huai'an, Huzhou, Jinan, Langfang, Luoyang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Xianyang, Zhengzhou, Zibo
Age
18 years and over
People
300
Run by
Hoffmann-La Roche
See details and how to joinNCT07670416
Phase 3Taking people
A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
Where
Beijing, Changchun, Changzhou, Chongqing, Hangzhou, Harbin, Hefei, Hengshui, Huizhou, Huzhou, Jinan, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Pingxiang, Shanghai, Shijiazhuang, Shiyan, Tianjin, Wuhan, Xi'an, Zhengzhou, Zhenjiang
Age
18 years and over
People
300
Run by
Pfizer
See details and how to joinNCT07792954
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 1Taking people
Study of UBT37034 Injection
Where
Changsha
Age
18 years to 55 years
People
40
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07873645
No phaseNot yet taking people in China
Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity
Where
Nanchang
Age
18 years to 60 years
People
150
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07898267
Phase 2Not yet taking people in China
A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes
Where
Changsha
Age
18 years to 55 years
People
160
Run by
BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07918625
Phase 3Taking people
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Where
Tainan, Taipei, Taoyuan
Age
6 years to 17 years
People
125 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672549
Phase 3Taking people
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Where
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Lanzhou, Nanjing, Ningbo, Shanghai, Shenzhen, Suzhou, Wuhan, Xiamen, Xi’an
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Beijing, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai, Tianjin, Zigong
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Where
Beijing, Bengbu, Changchun, Changsha, Chongqing, Hangzhou, Hefei, Jinan, Luoyang, Nanjing, Ningbo, Shanghai, Suzhou, Tianjin, Wenzhou, Wuhan, Xianyang
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Kunming, Lanzhou, Luoyang Shi, Nanchang, Nanjing, Nanning, Ningbo, Shanghai, Shenzhen, Suzhou, Wuxi, Xianyang
Age
18 years and over
People
800 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Hefei, Huzhou, Jinan, Luoyang Shi, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Wenzhou, Wuhan, Xianyang
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 4Taking people
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
Where
Chongqing, Hefei, Taiyuan, Wenzhou
Age
18 years to 65 years
People
285
Run by
The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07697391
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Changchun, Jinan, Luoyang Shi, Nanjing, Ningbo, Shijiazhuang, Tianjin
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 1Not yet taking people in China
A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants
Where
Chengdu, Chongqing, Zhengzhou
Age
18 years to 75 years
People
24
Run by
Beijing QL Biopharmaceutical Co.,Ltd
See details and how to joinNCT07916194
Phase 2Taking people
UBT251 Injection Phase II Clinical Study (CKD)
Where
Beijing
Age
18 years to 75 years
People
180
Run by
The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07134335